Hi-Red Nanoemulsion GluCut is on the right track to be commercialised in the local and global pharmaceutical markets soon, with one patent granted and one copyright registered.
Hi-Red Nanoemulsion GluCut was developed by Universiti Teknologi Malaysia (UTM) in collaboration with experienced industrial collaborators and a team of experts from the Biology and Chemistry Departments of the Faculty of Science. Roselle (Hibiscus sabdariffa) is a flowering plant native to West Africa in the Malvaceae family.
It’s also referred to as the Rosella fruit, Florida cranberry, or red sorrel. The roselle plant’s calyx is red and fleshy, with a tart, cranberry-like flavour. It contains a lot of antioxidants, vitamin C, and minerals like calcium, iron, and magnesium.
Aside from its culinary applications, the roselle plant is also used in traditional medicine for its various health benefits, including blood pressure and cholesterol reduction, digestion improvement, and immune system stimulation.
Meanwhile, researchers have been studying the anti-diabetic effect of roselle for nearly a decade, with a lot of experimental and formulation optimisation to achieve perfection in the hope of helping diabetic patients live healthier lives. “GluCut is a supplement made entirely of roselle extract.
“It is designed to stabilise blood glucose levels by slowing glucose absorption by the body and increasing insulin secretion as well as pancreas sensitivity,” said Dr. Siti Pauliena Mohd Bohari, Project Leader of UTM’s Animal Cell and Diabetologist Expert.
The combination of pure roselle extract with concentrated delphinidin-3-sambubioside using the nanoemulsion technique produced the finest and smoothest texture of emulsion for effortless direct consumption.
Visitors to one of the research exhibitions were drawn to the GluCut supplement. “GluCut’s nanotechnology formulation contains millions of lipid nano-sized particles that can easily target and penetrate cells.
Furthermore, GluCut may be superior to the anti-diabetic drug Glibenclamide in terms of insulin secretion. As a result, this formulation is appropriate for Type II Diabetes Mellitus patients. “Dr. Siti Pauliena also contributed. Along with Dr Siti Pauliena, the team includes UTM’s Biotechnologist and Nanoemulsion Expert, Assoc.
Prof. Ch.M Dr Roswanira Abdul Wahab; Dr Mariani Abdul Hamid, UTM’s Skincare Expert and the Founder and CEO of Biopro Consortium Sdn. Bhd.; and an enthusiastic PhD student, Nabill Afiff Abdul Samad.
This innovation recently received the Gold Medal Award and was named the Best of the Best Award winner, beating out 42 other competitors at the 24th Industrial Art & Technology Exhibition (INATEX 2022).
Dr. Siti Pauliena and her team won the Gold Medal Award and the Best of the Best Award at INATAEX 2022. Hi-Red Nanoemulsion GluCut is on the right track to be commercialised in the local and global pharmaceutical markets soon, with one patent granted and one copyright registered.